Trial
NCT05669417
Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated.
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
HagaZiekenhuis
Collaborators
—
Condition
Atrial Fibrillation New Onset
Intervention
Magnesium sulfate
Why stopped
Futility after interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-28